Title : Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells.

Pub. Date : 2006 Mar

PMID : 16546981






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In contrast, phosphorylation of Raf/mitogen-activated protein kinase kinase 1/2 (MEK 1/2)/ERK1/2 increased by bortezomib. Bortezomib mitogen-activated protein kinase 3 Homo sapiens